Penn Virginia (PVA) – Management Comments
-
pSivida (PSDV) Submits MAA for Approval of Durasert Three-year Treatment for Posterior Segment Uveitis in EU
-
pSivida (PSDV) Says Abstract on Treatment of Posterior Segment Uveitis Accepted for Presentation at ARVO
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PVA Stock Lookup